Connor, Clark & Lunn Investment Management (CC&L)’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-898
Closed -$272K 876
2017
Q3
$272K Sell
898
-84
-9% -$22K ﹤0.01% 715
2017
Q2
$229K Buy
982
+258
+36% +$67.5K ﹤0.01% 717
2017
Q1
$243K Buy
+724
New +$175K ﹤0.01% 769
2015
Q3
Sell
-1,918
Closed -$967K 797
2015
Q2
$967K Sell
1,918
-754
-28% -$346K 0.01% 346
2015
Q1
$1.35M Buy
2,672
+1,223
+84% +$746K 0.01% 275
2014
Q4
$868K Buy
+1,449
New +$581K 0.01% 325

Other funds holding ACGN

Connor, Clark & Lunn Investment Management (CC&L)'s ACGN Position: Q4 2017 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Aceragen Inc (ACGN) in Q4 2017, closing a stake of 898 shares — an estimated $272K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ACGN in Q4 2014 and held it in 6 quarters. The position peaked at $1.35M in Q1 2015. 106 funds tracked by Wall St. Rank hold ACGN as of Q4 2017.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Aceragen Inc position as of Q4 2017 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 898 Aceragen Inc shares in Q4 2017, an estimated $272K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Aceragen Inc in Q4 2014 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Aceragen Inc position peaked at $1.35M in Q1 2015.
  • 106 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2017.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2017, filed 9 Feb 2018.